Nitric oxide and pathogenic mechanisms involved in the development of vascular diseases

[1]  Luo Yu-yu.  Role of Krüppel-like transcription factors in endothelial biology , 2009 .

[2]  L. Lerman,et al.  The Interaction Between Coronary Endothelial Dysfunction, Local Oxidative Stress, and Endogenous Nitric Oxide in Humans , 2008, Hypertension.

[3]  M. Bouhlel,et al.  Peroxisome proliferator‐activated receptors – from active regulators of macrophage biology to pharmacological targets in the treatment of cardiovascular disease , 2007, Journal of internal medicine.

[4]  D. Harrison,et al.  Molecular Mechanisms of Angiotensin II–Mediated Mitochondrial Dysfunction: Linking Mitochondrial Oxidative Damage and Vascular Endothelial Dysfunction , 2007, Circulation research.

[5]  Paul L Huang,et al.  Cardiovascular roles of nitric oxide: a review of insights from nitric oxide synthase gene disrupted mice. , 2007, Cardiovascular research.

[6]  E. Schiffrin.  Oxidative stress, nitric oxide synthase, and superoxide dismutase: a matter of imbalance underlies endothelial dysfunction in the human coronary circulation. , 2008, Hypertension.

[7]  M. Toborek,et al.  The role of caveolin-1 in PCB77-induced eNOS phosphorylation in human-derived endothelial cells. , 2007, American journal of physiology. Heart and circulatory physiology.

[8]  Johan Kuiper,et al.  Prolonged shear stress and KLF2 suppress constitutive proinflammatory transcription through inhibition of ATF2. , 2007, Blood.

[9]  J. Kuiper,et al.  KLF2 Suppresses TGF-&bgr; Signaling in Endothelium Through Induction of Smad7 and Inhibition of AP-1 , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[10]  L. Ignarro,et al.  High glucose downregulates the number of caveolae in monocytes through oxidative stress from NADPH oxidase: implications for atherosclerosis. , 2007, Biochimica et biophysica acta.

[11]  C. Napoli,et al.  Polymorphisms in endothelial nitric oxide synthase and carotid artery atherosclerosis , 2006, Journal of Clinical Pathology.

[12]  C. Napoli,et al.  Nitric oxide and atherosclerosis: an update. , 2006, Nitric oxide : biology and chemistry.

[13]  N. Maniatis,et al.  Novel Mechanism of Endothelial Nitric Oxide Synthase Activation Mediated by Caveolae Internalization in Endothelial Cells , 2006, Circulation research.

[14]  M. Rondaij,et al.  KLF2 provokes a gene expression pattern that establishes functional quiescent differentiation of the endothelium. , 2006, Blood.

[15]  Yuzhi Zhang,et al.  Integration of flow-dependent endothelial phenotypes by Kruppel-like factor 2. , 2005, The Journal of clinical investigation.

[16]  T. Rabelink,et al.  Endothelial nitric oxide synthase: host defense enzyme of the endothelium? , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[17]  P. Reaven,et al.  Peroxisome Proliferator-Activated Receptor-Alpha and Atherosclerosis: From Basic Mechanisms to Clinical Implications , 2005, Cardiology.

[18]  Jurgen Seppen,et al.  Endothelial KLF2 links local arterial shear stress levels to the expression of vascular tone-regulating genes. , 2005, The American journal of pathology.

[19]  G. Garcı́a-Cardeña,et al.  Statins Exert Endothelial Atheroprotective Effects via the KLF2 Transcription Factor* , 2005, Journal of Biological Chemistry.

[20]  G. Garcı́a-Cardeña,et al.  Kruppel-Like Factor 2 (KLF2) Regulates Endothelial Thrombotic Function , 2005, Circulation research.

[21]  C. Napoli,et al.  Novel features of nitric oxide, endothelial nitric oxide synthase, and atherosclerosis , 2005, Current atherosclerosis reports.

[22]  F. Luscinskas,et al.  KLF2 Is a Novel Transcriptional Regulator of Endothelial Proinflammatory Activation , 2004, The Journal of experimental medicine.

[23]  D. Eichler,et al.  Argininosuccinate Synthase Expression Is Required to Maintain Nitric Oxide Production and Cell Viability in Aortic Endothelial Cells* , 2004, Journal of Biological Chemistry.

[24]  Xin Xu,et al.  Peroxisome Proliferator-Activated Receptor &agr; Agonists Increase Nitric Oxide Synthase Expression in Vascular Endothelial Cells , 2004 .

[25]  C. Napoli,et al.  Nitric oxide-releasing drugs. , 2003, Annual review of pharmacology and toxicology.

[26]  C. Napoli,et al.  Oxidation-sensitive mechanisms, vascular apoptosis and atherosclerosis. , 2003, Trends in molecular medicine.

[27]  V. Shah,et al.  The Proline-rich Domain of Dynamin-2 Is Responsible for Dynamin-dependent in Vitro Potentiation of Endothelial Nitric-oxide Synthase Activity via Selective Effects on Reductase Domain Function* , 2003, The Journal of Biological Chemistry.

[28]  J. Loscalzo,et al.  Glycoxidized low-density lipoprotein downregulates endothelial nitricoxide synthase in human coronary cells. , 2002, Journal of the American College of Cardiology.

[29]  J. Loscalzo,et al.  Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide: an overview. , 2002, Circulation research.

[30]  C. Napoli,et al.  Age-Related Effects on Atherogenesis and Scavenger Enzymes of Intracranial and Extracranial Arteries in Men Without Classic Risk Factors for Atherosclerosis , 2001, Stroke.

[31]  C. Napoli,et al.  Involvement of oxidation-sensitive mechanisms in the cardiovascular effects of hypercholesterolemia. , 2001, Mayo Clinic proceedings.

[32]  C. Napoli,et al.  Nitric oxide and atherosclerosis. , 2001, Nitric oxide : biology and chemistry.

[33]  C. Napoli,et al.  Nitric oxide as a signaling molecule in the vascular system: an overview. , 1999, Journal of cardiovascular pharmacology.

[34]  C. Napoli,et al.  Intracranial arteries of human fetuses are more resistant to hypercholesterolemia-induced fatty streak formation than extracranial arteries. , 1999, Circulation.

[35]  Roger Fan,et al.  Dynamic activation of endothelial nitric oxide synthase by Hsp90 , 1998, Nature.

[36]  C. Napoli,et al.  Mildly oxidized low-density lipoprotein impairs responses of carotid but not basilar artery in rabbits. , 1997, Stroke.